Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

Avadel Pharmaceuticals (Nasdaq: AVDL) has announced its upcoming participation in the Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET. Interested parties can access a live webcast of the discussion through Avadel's Investor Relations website at investors.avadel.com, where the recording will remain available for 90 days after the conference.

News Market Reaction – AVDL

-8.59%

-8.59% Session move

In the trading session that priced this news, AVDL declined 8.59%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc 

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ^TM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com. 

Investor Contact:
Courtney Mogerley
Precision AQ
Courtney.Mogerley@precisionAQ.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162

FAQ

When is Avadel Pharmaceuticals (AVDL) presenting at the Jefferies London Healthcare Conference?

Avadel Pharmaceuticals will present on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET.

How can I watch Avadel Pharmaceuticals' (AVDL) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast on Avadel's Investor Relations website at investors.avadel.com.

How long will Avadel Pharmaceuticals' (AVDL) Jefferies Conference presentation be available online?

The recorded presentation will be available on Avadel's Investor Relations website for 90 days following the conference.

What type of presentation will Avadel Pharmaceuticals (AVDL) give at the Jefferies Conference?

Avadel Pharmaceuticals' management will participate in a fireside chat format presentation.